TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

Clinical trial NCT00057720 · COMPLETED

Trial details

NCT number: NCT00057720
Sponsor: Telik
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2003-06-01
Primary completion: 2006-12-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.